Acetylated tau exacerbates learning and memory impairment by disturbing with mitochondrial homeostasis
Open accessAbstract
Increased tau acetylation at K274 and K281 has been observed in the brains of Alzheimer's disease (AD) patients and animal models, and mitochondrial dysfunction are noticeable and early features of AD. However, the effect of acetylated tau on mitochondria has been unclear until now. Here, we constructed three type of tau forms, acetylated tau mutant by mutating its K274/K281 into Glutamine (TauKQ) to mimic disease-associated lysine acetylation, the non-acetylation tau mutant by mutating its K274/K281 into Arginine (TauKR) and the wild-type human full-length tau (TauWT). By overexpression of these tau forms in vivo and in vitro, we found that, TauKQ induced more severe cognitive deficits with neuronal loss, dendritic plasticity damage and mitochondrial dysfunctions than TauWT. Unlike TauWT induced mitochondria fusion, TauKQ not only induced mitochondria fission by decreasing mitofusion proteins, but also inhibited mitochondrial biogenesis via reduction of PGC-1a/Nrf1/Tfam levels. TauKR had no significant difference in the cognitive and mitochondrial abnormalities compared with TauWT. Treatment with BGP-15 rescued impaired learning and memory by attenuation of mitochondrial dysfunction, neuronal loss and dendritic complexity damage, which caused by TauKQ. Our data suggested that, acetylation at K274/281 was an important post translational modification site for tau neurotoxicity, and BGP-15 is a potential therapeutic drug for AD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Acetylation at the K274/281 site is an important post-translational modification for tau neurotoxicity.
“Acetylation at the K274/281 site is an important post-translational modification for tau neurotoxicity”
From Role of Tau Protein in Neurodegenerative Diseases and Development of Its Targeted Drugs: A Literature Review (2024) · cites this paper as [81]
BGP-15 is a potential therapeutic agent for AD.
“and BGP-15 is a potential therapeutic agent for AD [81].”
From Role of Tau Protein in Neurodegenerative Diseases and Development of Its Targeted Drugs: A Literature Review (2024) · cites this paper as [81]
Cites
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853 · see citing works
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · see citing works
Sample size determination and power analysis using the G*Power software
Kang, H. (2021) · Journal of Educational Evaluation for Health Professions · doi:10.3352/jeehp.2021.18.17 · Cited by 2,572 · see citing works
The cell biology of mitochondrial membrane dynamics
Giacomello, M., Pyakurel, A., Glytsou, C., & Scorrano, L. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0210-7 · Cited by 1,550 · see citing works
Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases
Chen, H., & Chan, D. C. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp326 · Cited by 1,455 · see citing works
Mitochondrial dynamics: overview of molecular mechanisms
Tilokani, L., Nagashima, S., Paupe, V., & Prudent, J. (2018) · Essays in Biochemistry · doi:10.1042/ebc20170104 · Cited by 1,397 · see citing works
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: Recent advances.
Wang, W., Zhao, F., Ma, X., Perry, G., & Zhu, X. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00376-6 · Cited by 1,274 · see citing works
Mitochondrial dynamics and apoptosis
Suen, D.-F., Norris, K. L., & Youle, R. J. (2008) · Genes & Development · doi:10.1101/gad.1658508 · Cited by 1,270 · see citing works
Cogliati, S., Frezza, C., Soriano, M. E., Varanita, T., Quintana-Cabrera, R., Corrado, M., Cipolat, S., Costa, V., Casarin, A., Gomes, L. C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.032 · Cited by 1,265 · see citing works
Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations
Murphy, M. P., & Smith, R. A. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105110 · Cited by 1,173 · see citing works
Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease
Giannakopoulos, P., Herrmann, F. R., Bussière, T., Bouras, C., Kövari, E., Perl, D. P., Morrison, J. H., Gold, G., & Hof, P. R. (2003) · Neurology · doi:10.1212/01.wnl.0000063311.58879.01 · Cited by 1,118 · see citing works
Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
Min, S.-W., Cho, S.-H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W. W., Huang, E. J., Shen, Y., Masliah, E., Mukherjee, C., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.044 · Cited by 949 · see citing works
Yao, J., Irwin, R. W., Zhao, L., Nilsen, J., Hamilton, R. T., & Brinton, R. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903563106 · Cited by 940 · see citing works
Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms
Kerr, J. S., Adriaanse, B. A., Greig, N. H., Mattson, M. P., Cader, M. Z., Bohr, V. A., & Fang, E. F. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.01.002 · Cited by 870 · see citing works
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease
Bejanin, A., Schonhaut, D. R., La Joie, R., Kramer, J. H., Baker, S. L., Sosa, N., Ayakta, N., Cantwell, A., Janabi, M., Lauriola, M., et al. (2017) · Brain · doi:10.1093/brain/awx243 · Cited by 778 · see citing works
The acetylation of tau inhibits its function and promotes pathological tau aggregation
Cohen, T. J., Guo, J. L., Hurtado, D. E., Kwong, L. K., Mills, I. P., Trojanowski, J. Q., & Lee, V. M. Y. (2011) · Nature Communications · doi:10.1038/ncomms1255 · Cited by 724 · see citing works
Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease
Wesseling, H., Mair, W., Kumar, M., Schlaffner, C. N., Tang, S., Beerepoot, P., Fatou, B., Guise, A. J., Cheng, L., Takeda, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.029 · Cited by 688 · see citing works
Park, M. W., Cha, H. W., Kim, J., Kim, J. H., Yang, H., Yoon, S., Boonpraman, N., Yi, S. S., Yoo, I. D., & Moon, J.-S. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101947 · Cited by 683 · see citing works
Acetylation of the C Terminus of Ku70 by CBP and PCAF Controls Bax-Mediated Apoptosis
Cohen, H. Y., Lavu, S., Bitterman, K. J., Hekking, B., Imahiyerobo, T. A., Miller, C. M., Frye, R. A., Ploegh, H. L., Kessler, B. M., & Sinclair, D. A. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00094-2 · Cited by 574 · see citing works
HSP72 protects against obesity-induced insulin resistance
Chung, J., Nguyen, A.-K., Henstridge, D. C., Holmes, A. G., Chan, M. H. S., Mesa, J. L., Lancaster, G. I., Southgate, R. J., Bruce, C. R., Duffy, S. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705799105 · Cited by 553 · see citing works
Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment
Golpich, M., Amini, E., Mohamed, Z., Raymond, A. A., Ibrahim, N. M., & Ahmadiani, A. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12655 · Cited by 540 · see citing works
Impaired Mitochondrial Biogenesis Contributes to Mitochondrial Dysfunction in Alzheimer's Disease
Sheng, B., Wang, X.-L., Su, B., Lee, H.-G., Casadesus, G., Perry, G., & Zhu, X.-W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07581.x · Cited by 538 · see citing works
Self-citationWang, J., Xia, Y., Grundke, I., & Iqbal, K. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129031 · Cited by 530 · see citing works
Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits
Min, S.-W., Chen, X., Tracy, T. E., Li, Y., Zhou, Y., Wang, C., Shirakawa, K., Minami, S. S., Defensor, E., Mok, S. A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3951 · Cited by 516 · see citing works
Zhang, Z., Song, M., Liu, X., Kang, S. S., Kwon, I.-S., Duong, D. M., Seyfried, N. T., Hu, W. T., Liu, Z., Wang, J.-Z., et al. (2014) · Nature Medicine · doi:10.1038/nm.3700 · Cited by 494 · see citing works
Self-citationMorris, M., Knudsen, G. M., Maeda, S., Trinidad, J. C., Ioanoviciu, A., Burlingame, A. L., & Mucke, L. (2015) · Nature Neuroscience · doi:10.1038/nn.4067 · Cited by 472 · see citing works
Mitochondrial biogenesis and dynamics in the developing and diseased heart
Dorn, G. W., Vega, R. B., & Kelly, D. P. (2015) · Genes & Development · doi:10.1101/gad.269894.115 · Cited by 470 · see citing works
Mańczak, M., & Reddy, P. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds072 · Cited by 453 · see citing works
Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice
David, D. C., Hauptmann, S., Scherping, I., Schuessel, K., Keil, U., Rizzu, P., Ravid, R., Dröse, S., Brandt, U., Müller, W. E., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500356200 · Cited by 447 · see citing works
Wang, J.-Z., Grundke-Iqbal, I., & Iqbal, K. (1996) · Nature Medicine · doi:10.1038/nm0896-871 · Cited by 360 · see citing works
Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia
Niizuma, K., Yoshioka, H., Chen, H., Kim, G. S., Jung, J. E., Katsu, M., Okami, N., & Chan, P. H. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.09.002 · Cited by 360 · see citing works
Gong, B., Pan, Y., Vempati, P., Zhao, W., Knable, L., Ho, L., Wang, J., Sastre, M., Ono, K., Sauve, A. A., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.005 · Cited by 345 · see citing works
A neurological perspective on mitochondrial disease
McFarland, R., Taylor, R. W., & Turnbull, D. M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70116-2 · Cited by 315 · see citing works
Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies
Irwin, D. J., Cohen, T. J., Grossman, M., Arnold, S. E., Xie, S. X., Lee, V. M.-Y., & Trojanowski, J. Q. (2012) · Brain · doi:10.1093/brain/aws013 · Cited by 281 · see citing works
Tracy, T. E., Sohn, P. D., Minami, S. S., Wang, C., Min, S.-W., Li, Y., Zhou, Y., Le, D., Lo, I., Ponnusamy, R., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.005 · Cited by 277 · see citing works
Wu, L., Russell, D. L., Wong, S. L., Chen, M., Tsai, T., John, J. C. S., Norman, R. J., Febbraio, M. A., Carroll, J., & Robker, R. L. (2015) · Development · doi:10.1242/dev.114850 · Cited by 276 · see citing works
Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease
Golpich, M., Amini, E., Hemmati, F., Ibrahim, N. M., Rahmani, B., Mohamed, Z., Raymond, A. A., Dargahi, L., Ghasemi, R., & Ahmadiani, A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.010 · Cited by 276 · see citing works
Hsp72 preserves muscle function and slows progression of severe muscular dystrophy
Gehrig, S. M., van der Poel, C., Sayer, T. A., Schertzer, J. D., Henstridge, D. C., Church, J. E., Lamon, S., Russell, A. P., Davies, K. E., Febbraio, M. A., et al. (2012) · Nature · doi:10.1038/nature10980 · Cited by 274 · see citing works
Uittenbogaard, M. N., & Chiaramello, A. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140305224906 · Cited by 240 · see citing works
Luo, H.-B., Xia, Y.-Y., Shu, X.-J., Liu, Z.-C., Feng, Y., Liu, X.-H., Yu, G., Yin, G., Xiong, Y.-S., Zeng, K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417548111 · Cited by 236 · see citing works
Self-citationReducing acetylated tau is neuroprotective in brain injury
Shin, M.-K., Vázquez-Rosa, E., Koh, Y., Dhar, M., Chaubey, K., Cintrón-Pérez, C. J., Barker, S., Miller, E., Franke, K., Noterman, M. F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.032 · Cited by 226 · see citing works
Li, H.-L., Wang, H.-H., Liu, S.-J., Deng, Y.-Q., Zhang, Y.-J., Tian, Q., Wang, X.-C., Chen, X., Yang, Y., Zhang, J.-Y., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609303104 · Cited by 225 · see citing works
Self-citationFeng, Q., Luo, Y., Zhang, X., Yang, X., Hong, X.-Y., Sun, D., Li, X., Hu, Y., Li, X., Zhang, J., et al. (2019) · Autophagy · doi:10.1080/15548627.2019.1633862 · Cited by 211 · see citing works
Self-citationHenstridge, D. C., Bruce, C. R., Drew, B. G., Tory, K., Kolonics, A., Estevez, E., Chung, J., Watson, N., Gardner, T., Lee-Young, R. S., et al. (2014) · Diabetes · doi:10.2337/db13-0967 · Cited by 201 · see citing works
Altered brain energetics induces mitochondrial fission arrest in Alzheimer’s Disease
Zhang, L., Trushin, S., Christensen, T. A., Bachmeier, B. V., Gateno, B., Schroeder, A., Yao, J., Itoh, K., Sesaki, H., Poon, W. W., et al. (2016) · Scientific Reports · doi:10.1038/srep18725 · Cited by 198 · see citing works
Romanello, V., & Sandri, M. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03662-0 · Cited by 197 · see citing works
Regulation of neuron mitochondrial biogenesis and relevance to brain health
Onyango, I. G., Lu, J., Rodova, M., Lezi, E., Crafter, A. B., & Swerdlow, R. H. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.014 · Cited by 188 · see citing works
Yin, Y., Gao, D., Wang, Y., Wang, Z.-H., Wang, X., Ye, J., Wu, D., Fang, L., Pi, G., Yang, Y., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604519113 · Cited by 174 · see citing works
Self-citationCaspase-cleaved Tau Expression Induces Mitochondrial Dysfunction in Immortalized Cortical Neurons
Quintanilla, R. A., Matthews-Roberson, T. A., Dolan, P. J., & Johnson, G. V. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808908200 · Cited by 170 · see citing works
Why size matters – balancing mitochondrial dynamics in Alzheimer's disease
DuBoff, B., Feany, M. Β., & Götz, J. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.03.002 · Cited by 164 · see citing works
Li, X., Hu, Y., Wang, Z.-H., Luo, Y., Zhang, Y., Liu, X., Feng, Q., Wang, Q., Ye, K., Liu, G., et al. (2016) · Scientific Reports · doi:10.1038/srep24756 · Cited by 164 · see citing works
Self-citationDumont, M., Kipiani, K., Yu, F., Wille, E. J., Katz, M., Calingasan, N. Y., Gouras, G. K., Lin, M. T. S., & Beal, M. F. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110209 · Cited by 161 · see citing works
Medication‐induced mitochondrial damage and disease
Neustadt, J. O., & Pieczenik, S. R. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700075 · Cited by 158 · see citing works
Zheng, J., Li, H., Tian, N., Liu, F., Wang, L., Yin, Y., Yue, L., Ma, L., Wan, Y., & Wang, J. (2020) · Cell stem cell · doi:10.1016/j.stem.2019.12.015 · Cited by 155 · see citing works
Mitoguardin regulates mitochondrial fusion through MitoPLD and is required for neuronal homeostasis.
Zhang, Y., Liu, X., Bai, J., Tian, X., Zhao, X., Liu, W., Duan, X., Shang, W., Fan, H.-Y., & Tong, C. (2016) · Molecular Cell · doi:10.1016/j.molcel.2015.11.017 · Cited by 145 · see citing works
FLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease
Mair, W., Muntel, J., Tepper, K., Tang, S., Biernat, J., Seeley, W. W., Kosik, K. S., Mandelkow�, E., Steen, H., & Steen, J. A. J. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04509 · Cited by 144 · see citing works
Halmosi, R., Berente, Z., Ősz, E., Tóth, K., Literati-Nagy, P., & Sümegi, B. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1497 · Cited by 140 · see citing works
Tau: From research to clinical development
Holtzman, D. M., Carrillo, M. C., Hendrix, J. A., Bain, L. J., Catafau, A. M., Gault, L. M., Goedert, M., Mandelkow, E., Mandelkow, E., Miller, D. S., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.018 · Cited by 139 · see citing works
The dentate gyrus neurogenesis: a therapeutic target for Alzheimer's disease
Tatebayashi, Y., Lee, M. H., Li, L., Iqbal, K., & Grundke, I. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0636-3 · Cited by 126 · see citing works
Exercise induces mitochondrial biogenesis after brain ischemia in rats
Zhang, Q., Wu, Y., Zhang, P., Sha, H., Jia, J., Hu, Y., & Zhu, J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.053 · Cited by 121 · see citing works
Self-citationFoote, K., Reinhold, J., Yu, E., Figg, N. L., Finigan, A. J., Murphy, M. P., & Bennett, M. R. (2018) · Aging Cell · doi:10.1111/acel.12773 · Cited by 120 · see citing works
Literáti-Nagy, B., Kulcsár, E., Literáti-Nagy, Z., Buday, B., Péterfai, E., Horváth, T., Tory, K., Kolonics, A., Fleming, A., Mandl, J., et al. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0028-1128142 · Cited by 113 · see citing works
O‐GlcNAcylation: A regulator of tau pathology and neurodegeneration
Gong, C., Liu, F., & Iqbal, K. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.02.011 · Cited by 111 · see citing works
Yang, Y., Wang, Z.-H., Jin, S., Gao, D., Liu, N., Chen, S., Zhang, S., Liu, Q., Liu, E., Wang, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms11935 · Cited by 111 · see citing works
Self-citationThe small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice
Sapra, G., Tham, Y. K., Cemerlang, N., Matsumoto, A., Kiriazis, H., Bernardo, B. C., Henstridge, D. C., Ooi, J. Y. Y., Pretorius, L., Boey, E. J. H., et al. (2014) · Nature Communications · doi:10.1038/ncomms6705 · Cited by 107 · see citing works
Rácz, I., Tory, K., Gallyas, F., Berente, Z., Ősz, E., Jaszlits, L., Bernath, S., Sümegi, B., Rabloczky, G., & Literati-Nagy, P. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00935-2 · Cited by 97 · see citing works
Activation of mitochondrial fusion provides a new treatment for mitochondria-related diseases
Szabó, A., Sümegi, K., Fekete, K., Hocsák, E., Debreceni, B., Sétáló, G., Kovács, K., Deres, L., Kengyel, A. M., Kovács, D., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.038 · Cited by 92 · see citing works
Szabados, E., Literati-Nagy, P., Farkas, B., & Sümegi, B. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00418-9 · Cited by 84 · see citing works
Tau accumulation triggers STAT1‐dependent memory deficits by suppressing NMDA receptor expression
Li, X., Hong, X., Wang, Y., Zhang, S., Zhang, J., Li, X., Liu, Y., Sun, D., Feng, Q., Ye, J., et al. (2019) · The EMBO Reports · doi:10.15252/embr.201847202 · Cited by 81 · see citing works
Self-citationA novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies
Zheng, J., Tian, N., Liu, F., Zhang, Y., Su, J., Gao, Y., Deng, M., Wei, L., Ye, J., Li, H., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00669-2 · Cited by 78 · see citing works
Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept
Epelbaum, S., Genthon, R., Cavedo, E., Habert, M. O., Lamari, F., Gagliardi, G. P., Lista, S., Teichmann, M., Bakardjian, H., Hampel, H. J., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.12.003 · Cited by 77 · see citing works
The chaperone co-inducer BGP-15 alleviates ventilation-induced diaphragm dysfunction
Salah, H. A., Li, M., Cacciani, N., Gastaldello, S., Ogilvie, H., Akkad, H., Namuduri, A. V., Morbidoni, V., Artemenko, K. A., Balogh, G. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf7099 · Cited by 76 · see citing works
Wang, J., Wang, Z.-H., & Tian, Q. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1415-y · Cited by 74 · see citing works
Peng, C., Hu, J., Liu, D., Hong, X., Wu, Y., Zhu, L., & Wang, J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.010 · Cited by 74 · see citing works
Self-citationPhosphorylated tau potentiates Aβ-induced mitochondrial damage in mature neurons
Quintanilla, R. A., Rommy von Bernhardi, M., Godoy, J. A., Inestrosa, N. C., & Johnson, G. V. W. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.016 · Cited by 72 · see citing works
Acetylated tau in Alzheimer's disease: An instigator of synaptic dysfunction underlying memory loss
Tracy, T. E., & Gan, L. (2017) · BioEssays · doi:10.1002/bies.201600224 · Cited by 72 · see citing works
BGP-15 inhibits caspase-independent programmed cell death in acetaminophen-induced liver injury
Nagy, G., Szarka, A., Lotz, G., Dóczi, J., Wunderlich, L., Kiss, A., Jemnitz, K., Veres, Z., Bánhegyi, G., Schaff, Z., et al. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.11.017 · Cited by 63 · see citing works
Calkins, M. J., & Reddy, P. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.006 · Cited by 62 · see citing works
BGP-15 prevents the death of neurons in a mouse model of familial dysautonomia
Ohlen, S. B., Russell, M. L., Brownstein, M., & Lefcort, F. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620212114 · Cited by 59 · see citing works
Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains
Arakhamia, T., Lee, C. E., Carlomagno, Y., Kumar, M., Duong, D. M., Wesseling, H., Kundinger, S. R., Wang, K., Williams, D., Deture, M. A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.11.029 · Cited by 57 · see citing works
Sárszegi, Z., Bognar, E., Gaszner, B., Kónyi, A., Gallyas, F., Sümegi, B., & Berente, Z. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1252-8 · Cited by 55 · see citing works
Bárdos, G. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00155-8 · Cited by 50 · see citing works
A possible overestimation of the effect of acetylation on lysine residues in KQ mutant analysis
Fujimoto, H., Higuchi, M., Koike, M., Ode, H., Pinák, M., Bunta, J. K., Nemoto, T., Sakudoh, T., Honda, N., Maekawa, H., et al. (2011) · Journal of Computational Chemistry · doi:10.1002/jcc.21956 · Cited by 46 · see citing works
Zhang, Q., Yu, J., Wang, P., Chen, W., Wu, Z., Jiang, H. F., & Tan, L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.074 · Cited by 37 · see citing works
Kennedy, T. L., Swiderski, K., Murphy, K. T., Gehrig, S. M., Curl, C. L., Chandramouli, C., Febbraio, M. A., Delbridge, L. M. D., Koopman, R., & Lynch, G. S. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.08.008 · Cited by 36 · see citing works
Gorsky, M. K., Burnouf, S., Sofola-Adesakin, O., Dols, J., Augustin, H., Weigelt, C. M., Grönke, S., & Partridge, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-10225-0 · Cited by 36 · see citing works
Bonda, D., Smith, M. A., Perry, G. L., Lee, H., Wang, X., & Zhu, X. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072562 · Cited by 34 · see citing works
Self-citationPreconditioning as a Potential Strategy for the Prevention of Parkinson’s Disease
Golpich, M., Rahmani, B., Ibrahim, N. M., Dargahi, L., Mohamed, Z., Raymond, A. A., & Ahmadiani, A. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8689-6 · Cited by 26 · see citing works
Horváth, O., Ördög, K., Bruszt, K., Deres, L., Gallyas, F., Sümegi, B., Tóth, K., & Halmosi, R. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1250858 · Cited by 25 · see citing works
Meng, D., Yang, M., Hu, L., Liu, T., Zhang, H., Sun, X., Wang, X., Chen, Y., Jin, Y. T., & Liu, R. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15701 · Cited by 25 · see citing works
Self-citationJiang, X. J., Wu, Y. Q., Ma, R., Chang, Y. M., Li, L. L., Zhu, J. H., Liu, G. P., & Li, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.736267 · Cited by 22 · see citing works
Self-citationEacott, M. J., & Gaffan, D. (1989) · Brain · doi:10.1093/brain/112.5.1215 · Cited by 10 · see citing works
Flagged first, then by citations
2 of the 94 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Choi, E.-H., Kim, M.-H., & Park, S.-J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147952 · Cited by 109 · see citing works
“…dynamics by decreasing the expression levels of the fusion proteins MFN1, MFN2 and OPA1 and by inhibiting biogenesis through the PGC − 1 α /Nrf1/Tfam signaling pathway, which confirms that acetylated tau exacerbates severe cognitive deficits with neuronal loss and dendritic plasticity damage [85].”
BackgroundYang, J., Zhi, W., & Wang, L. (2024) · Molecules · doi:10.3390/molecules29122812 · Cited by 63 · see citing works
“Increased tau acetylation at the K274 and K281 loci has been observed in the brain in AD patients and animal models, and acetylation at the K274/281 locus is an important site of post-translational modification for tau neurotoxicity [81].”
BackgroundWang, X., Liu, Q., Yu, H., Xie, J., Zhao, J., Fang, Z.-T., Qu, M., Zhang, Y., Yang, Y., & Wang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01812-5 · Cited by 60 · see citing works
Self-citationBGP-15 alleviates LPS-induced depression-like behavior by promoting mitophagy
Liu, Q. R., Zhao, J., Fang, Z., Wang, X., Zhang, B., He, Y., Liu, R., Chen, J., & Liu, G. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.036 · Cited by 59 · see citing works
Self-citationGu, Y., Zhao, X., Zhang, N., Yang, Y., Yi, Y., Shao, Q.-H., Liu, M.-X., & Zhang, X.-L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102577 · Cited by 58 · see citing works
The Role and Pathogenesis of Tau Protein in Alzheimer’s Disease
Hong, X.-Y., Huang, L., Lei, F., Li, T., Luo, Y., Zeng, M., & Wang, Z. (2025) · Biomolecules · doi:10.3390/biom15060824 · Cited by 52 · see citing works
“Tau acetylation at K274/K281 induces mitochondrial fission by reducing mitofusion proteins and inhibits mitochondrial biogenesis through the downregulation of PGC-1a/Nrf1/Tfam [106,152].”
Bai, H., Wu, Y., Li, H., Zhu, Y., Che, R., Wang, F., & Zhang, C. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.169511 · Cited by 48 · see citing works
Self-citationLi, R., Ma, Y., Wu, H., Zhang, X., Ding, N., Li, Z., Hu, X., Rao, J., Zhou, Y., Wang, L., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01160-2 · Cited by 33 · see citing works
“Inflammatory mediators and oxidative stress can induce changes in the mitochondrial inner membrane and disrupt the electron transport chain, thereby leading to dissipation of the mitochondrial membrane potential (ΔΨ), a critical indicator of mitochondrial health (Liu et al. 2023).”
Yang, J., Shen, N., Shen, J., Yang, Y., & Li, H.-L. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03867-x · Cited by 32 · see citing works
“However, BGP-15, a poly (ADP-ribose) polymerase (PARP) inhibitor and insulin sensitizer [71], is a potential therapeutic agent for AD as it mitigates these impairments in memory and learning via attenuating the aforementioned impairments caused by acetylation of tau at K274 and K281 [70, 72].”
BackgroundBioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer’s disease
Wasim, R. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01916-6 · Cited by 30 · see citing works
“Extending these findings in an in vivo context, Liu et al. (2023) reported that acetylated tau contributes to learning and memory impairments in animal models by disturbing mitochondrial homeostasis in neurons.”
Synaptic sabotage: How Tau and α-Synuclein undermine synaptic health
Uytterhoeven, V., Verstreken, P., & Nachman, E. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202409104 · Cited by 28 · see citing works
Meng, L., Ouyang, Z., Chen, Y., Huang, C., Yu, Y., & Fan, R. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.172655 · Cited by 25 · see citing works
Self-citationAlrouji, M., Alshammari, M. S., Syed, T., & Shamsi, A. (2025) · Antioxidants · doi:10.3390/antiox14070774 · Cited by 21 · see citing works
“Acetylation of the lysine 280 residue is significant for tau phosphorylation [138,140,141].”
Liu, Q. R., Wang, X., Fang, Z., Zhao, J.-N., RUI, X., Zhang, B., He, Y., Liu, R., Chen, J., Chai, G., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2431472 · Cited by 20 · see citing works
“The MWM test, performed according to the improved experimental method established in our lab, was conducted as follows [63].”
Self-citationRen, J., Xiang, B., Song, L., René, D. J., Luo, Y., Wen, G., Gu, H., Yang, Z., & Zhang, Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156170 · Cited by 19 · see citing works
Estrella, L. D., Trease, A. J., Sheldon, L., Roland, N. J., Fox, H. S., & Stauch, K. L. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.12.006 · Cited by 18 · see citing works
Selenoprotein W modulates tau homeostasis in an Alzheimer’s disease mouse model
Ren, B., Situ, J., Huang, X., Tan, Q., Xiao, S., Li, N., Tian, J., Du, X., Ni, J., & Liu, Q. (2024) · Communications Biology · doi:10.1038/s42003-024-06572-0 · Cited by 17 · see citing works
“Tau K281 acetylation may accelerate AD progression by disrupting MT stabilization, enhancing fi brillar tau aggregate formation, and disturbing mitochondrial homeostasis 49,50 .”
Self-citationDonato, L., Mordà, D., Scimone, C., Alibrandi, S., D’Angelo, R., & Sidoti, A. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.03.025 · Cited by 13 · see citing works
Zhang, J., Zhao, X., Tang, J. P., Liu, C., Zhang, Y., Cai, C., & Du, Q. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02214-w · Cited by 13 · see citing works
Han, X., Zhang, B., Gong, Q., Liu, T., Wang, C., Sun, Y., Jia, H., pu, Y., Hou, Q., & Yang, X. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.10.281 · Cited by 12 · see citing works
Self-citationAcetylated tau exacerbates apoptosis by disturbing mitochondrial dynamics in HEK293 cells
Zhang, J., Fang, Z., Zhao, J., Liu, G., Shen, X., Jiang, G., & Liu, Q. R. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16053 · Cited by 11 · see citing works
“…specific disorders associated with mitochondrial dysfunction, involving the regulation of mitochondrial dynamic homeostasis, but up to now there is no information about its affecting a known receptor or specific binding protein (Al-Zubaidi et al., 2021; Gyongyosi et al., 2023; Liu et al., 2023 ).”
BackgroundSelf-citationChen, P., Ye, C., Huang, Y., Xu, B., Wu, T., Dong, Y., Jin, Y., Zhao, L., Hu, C., Mao, J., et al. (2024) · Biological Research · doi:10.1186/s40659-024-00492-3 · Cited by 13 · see citing works
“We also found decreased MMP, ATP production, and OCR of mitochondria, along with increased mitochondrial ROS levels in TGF-β1-activated ESCs, indicating excessive oxidative stress and mitochondrial dysfunction [59].”
BackgroundYao, J., He, Z., You, G., Liu, Q., & Li, N. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080402 · Cited by 9 · see citing works
Self-citationMitochondrial dynamics in neurodegenerative diseases: Research hotspots and trends from 2005 to 2025
Hu, S., Yang, Z., Bao, K., Hou, W., Qin, Y., Wu, C., Wang, Q., Luo, X., & Luo, L. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102987 · Cited by 9 · see citing works
Sorial, M. E. S., Abdelghany, R. M., & Sayed, N. S. E. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01695-0 · Cited by 8 · see citing works
“…interesting point for research in SAD as it has been found to contribute to memory deficits and disrupted mitochondrial assembly (Bryan et al. 2024; Liu et al. 2023), our focus was on phosphorylated tau as it was directly affected by insulin resistance and GSK 3 activation caused by ICV STZ…”
Oh, Y. R., & Shin, M. (2025) · BMB Reports · doi:10.5483/bmbrep.2025-0077 · Cited by 9 · see citing works
“In vivo , these acetylation mimetics intensify neuronal loss and cognitive decline (83).”
Bryan, M. R., Tian, X., Tseng, J., Evangelista, B., Ragusa, J. V., Bryan, A. F., Trotman, W., Irwin, D. J., & Cohen, T. J. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01865-1 · Cited by 8 · see citing works
Li, X., Ba, Z., Huang, J., Chen, J., Jiang, J., Huang, N., & Luo, Y. (2024) · Ibrain · doi:10.1002/ibra.12176 · Cited by 7 · see citing works
Lei, H., Chen, X., Ruan, L., Liu, X., Ye, F., Li, K., Cheng, W., Yu, B., Di, C., & Di, C. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102927 · Cited by 7 · see citing works
Yu, L., Yang, X., Lei, H.-P., Hu, Y., Wu, L., Zhou, S., & Jin, F. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05162-3 · Cited by 6 · see citing works
“This can lead to problems with thinking [133].”
Self-citationZhou, H.-L., Wang, B., Fan, X.-L., Zhang, X.-M., & Song, Y. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117484 · Cited by 6 · see citing works
Guo, C., Wang, Q., Li, J., Ji, W., Chen, L., Chang, M., Ma, L., Liu, X., & Ni, M. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01655-y · Cited by 5 · see citing works
“The primer sequences for both mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) ampli fi cation were designed according to previously validated sequences reported in the literature [30].”
Advances in Alzheimer’s disease: mechanistic insights and therapeutic targets
Jia, Y.-J., Ge, Y., Li, B., Yang, Y., Chen, H., Liu, J., Guo, J., Yu, J., Ye, K., Wang, J., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-2991-7 · Cited by 5 · see citing works
“This process involves the acetylation of lysines K174, K274, and K281, which has been observed particularly in the early stages of AD and more prominently in the brains of advanced AD patients with severe dementia (Liu et al., 2023b; Min et al., 2015).”
Making tau amyloid models in vitro: a crucial and underestimated challenge
Broc, J., Piersson, C., & Fichou, Y. (2025) · FEBS Letters · doi:10.1002/1873-3468.70022 · Cited by 5 · see citing works
“Synaptic loss was shown in cellula [87], and an increase in acetylation was negatively correlated to the axon initial segment cytoskeletal protein levels and proper cytoskeletal function in AD brain and several models [83].”
Wang, J., Yu, Z.-W., Liu, Q., Wu, J., Zhang, Y.-D., Wan, H., Bi, M., Xiao, N., Zheng, K.-M., & Jiang, B. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325799 · Cited by 4 · see citing works
“Several recent studies have linked tau proteins in AD to mitochondrial malfunctions [16,17].”
Self-citationTherapeutic importance of hydrogen sulfide in cognitive impairment diseases
Wei, H., Tan, H., Cao, J.-P., He, J., Zhang, Q., Jiang, L., Zhou, G., & Xiao, F. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149547 · Cited by 3 · see citing works
Zhong, S., Zhou, Q., Yang, J., Zhang, Z., Chai, X., Luo, J., Zhang, X., Liu, J., Yixi, Y., Shi, L., et al. (2026) · Environment & Health · doi:10.1021/envhealth.5c00504 · Cited by 3 · see citing works
Self-citationMeng, F., Cao, S., Wu, W.-F., Zhang, M., Jing, Q., Xie, Z., Sun, X., Song, J., Fei, M., QIAN Cunyuan, C. G., et al. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06095-3 · Cited by 3 · see citing works
Protein lysine acetylation regulates beef color stability during storage
Shu, Y., Lv, J., Lou, A., Quan, W., & Shen, Q. W. (2025) · LWT · doi:10.1016/j.lwt.2025.117468 · Cited by 3 · see citing works
Mitochondrial Dysfunction in Neurodegenerative Diseases
Chen, C., Zhao, Y., Wang, J., Pan, D., Wang, X., Xu, Y., Yan, J., Wang, L., Yang, X., Lu, M., et al. (2025) · MedComm · doi:10.1002/mco2.70326 · Cited by 3 · see citing works
“Acetylated Tau induced mitochondrial dysfunction by suppressing mitochondrial biogenesis and enhancing mitochondrial fission, thereby ultimately giving rise to cognitive impairment in AD model mice [147, 148].”
Self-citationNicotine Improves Memory Impairment in Aged Rats Through Enhanced Mitochondrial Homeostasis
Ni, Z., Li, Y., Wang, G., Wang, S., Chen, H., Hou, H., & Hu, Q. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05342-1 · Cited by 2 · see citing works
Self-citationBioenergetic impairment-induced Tau acetylation: Converging pathways in Alzheimer’s disease
C, B. K., & G., P. P. C. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.05.020 · Cited by 2 · see citing works
Lin, T., Tseng, P.-H., Chen, I., Lin, C., Lee, M.-C., Chang, K., Lee‐Chen, G., & Chen, C. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106042 · Cited by 1 · see citing works
Wang, J., Wang, J., Xie, W., Shen, Q., Wang, C., Li, R., & Deng, S. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101886 · Cited by 1 · see citing works
“32 Our findings suggested that alcohol disrupted mitochondrial homeostasis, leading to mitochondrial fragmentation and impaired function.”
Kara, B., Beck, J. S., Fu, Z., Hickey, S. L., Kanaan, N. M., Mufson, E. J., Ginsberg, S. D., & Counts, S. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02080-2 · Cited by 1 · see citing works
Understanding the impact of cytoskeleton disruption on synaptic plasticity in Alzheimer’s disease
Basavaraju, K. C., & Priyadarshini, P. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.020 · Cited by 1 · see citing works
Three alternative promoters govern PGC-1α expression in chicken and are directly repressed by PPARγ
Huang, J., Mu, F., Lou, M., Gao, F., Ning, B., Luo, H., Yan, X., Jing, Y., & Wang, N. (2026) · Poultry Science · doi:10.1016/j.psj.2026.106481 · Cited by 1 · see citing works
“Additionally, PGC-1 α expression is regulated post-transcriptionally via alternative splicing (Felder et al., 2011), RNA modification (Zhang et al., 2021), mRNA degradation, and translation (Liu et al., 2023; Trausch-Azar et al., 2010).”
Wang, Z., Jiang, X., Lin, J., An, R., He, Y., & Li, S. (2026) · Antioxidants · doi:10.3390/antiox15040515 · Cited by 1 · see citing works
“…has demonstrated that mitochondrial dysfunction in AD and related neurodegenerative diseases promotes pathological Tau modifications (including phosphorylation and acetylation), which further exacerbate mitochondrial impairment and establish a self-perpetuating cycle of degeneration [16,17].”
Self-citationOfferdahl, J. E. V., & Mor, D. E. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1846384 · Cited by 1 · see citing works
Emerging diagnostic biomarkers and therapeutic targets in Alzheimer's disease
Dineshbhai, T. K., Rafaliya, D., Singh, A., Maheshwari, S., Lalan, M. S., & Chakraborthy, G. S. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02341-z · Cited by 1 · see citing works
“BGP-15 reduces tau-related neurotoxicity, Multi-target therapy improves overall therapeutic outcome maintains neuronal integrity, and enhances cognitive performance (Liu et al. 2023).”
Song, D. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1886145 · Cited by 1 · see citing works
“In AD animal models, the expression of human total tau or phosphorylated tau leads to mitochondrial dysfunction (Liu et al., 2023).”
Liu, Q., & Liu, G. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.06.029 · Cited by 1 · see citing works
Self-citationJia, X., Liu, M. Y., Liang, Y., Zhang, Y., Li, S., Bai, M., & Yongqiang, D. U. A. N. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121584
Wang, L., Yin, L., Li, Y., Guo, F., Li, Q., Li, Y., mi, J., Huang, H., & Xu, J. (2026) · The FASEB Journal · doi:10.1096/fj.202505013rr
“Since BGP-15 ((O-(3- piperidino- 2- hydroxy- 1-propyl)- nicotinic amidoxime)) has been shown to attenuate mitochondrial dysfunction in several disease models [18–20], we explored the effect of BGP-15 on the mitochondria function of oocytes from T1D mice.”
Han, J., Wu, S., Cui, X., Zhou, X., Yu, Q., Cheng, Q., Lu, Z., & Zong, S. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.07.021
Hu, Z.-Y., Liu, R., Ouyang, Y.-X., Chen, M., Wang, J.-X., Lou, M., Huang, Y.-F., Si, H.-L., Jiang, F., Liu, Z.-Y., et al. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.143458
Sun, Y., Li, Y., Zhang, F., Wan, Z., Zhang, X., Xu, P., Wang, Y., Li, C., Zuo, Y., Liu, J., et al. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01833-3
Self-citationBasavaraju, K. C., & G., P. P. C. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154717
- Authors
- Liu, Q., Wang, X., Hu, Y., Zhao, J.-N., Huang, C.-H., Li, T., Zhang, B.-G., He, Y., Wu, Y.-Q., Zhang, Z.-J., Wang, G.-P., & Liu, G.-P.
- Affiliations
- Huazhong University of Science and Technology (CN)
- Nantong University (CN)
- Jinan University (CN)
- Corresponding author
- Liu, Gong-Ping
- Venue
- Redox Biology
- Publisher
- Elsevier BV
- Published
- 2023-06
- Volume
- 62
- Pages
- 102697
- ISSN
- 2213-2317 (ISSN-L)
- PMC
- PMC10114242
- OpenAlex
- W4362671000
- Cited by
- 58
- References
- 94
- Citations by year
- 2026: 15 · 2025: 20 · 2024: 20 · 2023: 3
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Redox Biology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81801069, 82061160374, 82073821)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- tau acetylation, lysine acetylation, Alzheimer's disease, mitochondrial dysfunction, mitochondrial fission, mitochondrial fusion, mitochondrial biogenesis, PGC-1α, NRF1, TFAM, learning and memory impairment, neuronal loss, dendritic plasticity, BGP-15, post-translational modification
- MeSH terms
- Alzheimer Disease, Animals, Disease Models, Animal, Humans, Mitochondria, Oximes, Piperidines, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review